Andon Health Soars 10% to Day High of CNY 79.87 Amid Strong Intraday Performance

Andon Health Co., Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 10.0% on May 22, 2026. The stock reached an intraday high of CNY 79.87, showcasing notable activity amid a mixed performance landscape. In terms of performance metrics, Andon Health has demonstrated resilience over the past year, with a remarkable increase of 106.7%, significantly outperforming the China Shanghai Composite, which rose by 21.68% during the same period. Year-to-date, the stock has also shown strong growth, up 99.48%, compared to the broader market's 3.63% gain. Despite these positive short-term trends, the company has faced challenges, including a decline in net sales of 11.69% and a net profit drop of 46.47% in its latest quarterly results. The company has reported negative results for the last 13 consecutive quarters, indicating ongoing financial pressures. With a market capitalization of CNY 33,914 million and a P/E ratio of 51.00, Andon Health continues to navigate a complex market environment while maintaining a large-cap status.